Drug shortages homepage

Welcome to Drug Shortages Canada, the website for reporting drug shortages and discontinuations in Canada. The Food and Drug Regulations require drug sellers to report when they are not able to meet demand for a product or when they stop selling a product. Information about the website and the regulations can be found on the About & Resources Page.

A shortage means, in respect of a drug, a situation in which the manufacturer to whom a document was issued under subsection C.01.014.2(1) that sets out the drug identification number assigned for the drug is unable to meet the demand for the drug.

Below are the newest and most recently updated Shortage and Discontinuation reports.

Drug pills

Shortage Reports

Brand name Company Name Status Strength Update Date Updated View Report
FLULAVAL TETRA ID BIOMEDICAL CORPORATION OF QUEBEC Actual shortage 15MCG 15MCG 15MCG 15MCG Updated Report 2019-09-17 94139
POTASSIUM CHLORIDE FOR INJECTION CONCENTRATE USP PFIZER CANADA ULC Actual shortage 149MG Updated Report 2019-09-17 78955
MYLAN-SIMVASTATIN MYLAN PHARMACEUTICALS ULC Actual shortage 80MG Updated Report 2019-09-17 17773
MYLAN-SIMVASTATIN MYLAN PHARMACEUTICALS ULC Actual shortage 40MG Updated Report 2019-09-17 17769
MYLAN-SIMVASTATIN MYLAN PHARMACEUTICALS ULC Actual shortage 20MG Updated Report 2019-09-17 51639
MYLAN-SIMVASTATIN MYLAN PHARMACEUTICALS ULC Actual shortage 10MG Updated Report 2019-09-17 51636
MYLAN-SIMVASTATIN MYLAN PHARMACEUTICALS ULC Actual shortage 5MG Updated Report 2019-09-17 38547
CREON MINIMICROSPHERES 25 BGP PHARMA ULC Actual shortage 25500UNIT 1600UNIT 25000UNIT Updated Report 2019-09-17 92740
MAVIK BGP PHARMA ULC Anticipated shortage 2MG Updated Report 2019-09-17 91626
KADIAN BGP PHARMA ULC Anticipated shortage 100MG New Report 2019-09-17 94104

Discontinuation Reports

Brand name Company Name Status Strength Update Date Updated View Report
MYLAN-SIMVASTATIN MYLAN PHARMACEUTICALS ULC To be discontinued 80MG New Report 2019-09-17 94132
MYLAN-SIMVASTATIN MYLAN PHARMACEUTICALS ULC To be discontinued 40MG New Report 2019-09-17 94127
MYLAN-SIMVASTATIN MYLAN PHARMACEUTICALS ULC To be discontinued 20MG New Report 2019-09-17 94122
MYLAN-SIMVASTATIN MYLAN PHARMACEUTICALS ULC To be discontinued 10MG New Report 2019-09-17 94117
MYLAN-SIMVASTATIN MYLAN PHARMACEUTICALS ULC To be discontinued 5MG New Report 2019-09-17 94112
MYLAN-MINOCYCLINE MYLAN PHARMACEUTICALS ULC To be discontinued 100MG Updated Report 2019-09-17 20180
MYLAN-MINOCYCLINE MYLAN PHARMACEUTICALS ULC To be discontinued 50MG New Report 2019-09-17 94055
MYLAN-BUPRENORPHINE/NALOXONE MYLAN PHARMACEUTICALS ULC To be discontinued 8MG 2MG New Report 2019-09-17 94048
MYLAN-BUPRENORPHINE/NALOXONE MYLAN PHARMACEUTICALS ULC To be discontinued New Report 2019-09-17 94044
OXYCODONE PRO DOC LIMITEE To be discontinued 20MG New Report 2019-09-16 93999
OXYCODONE PRO DOC LIMITEE To be discontinued 10MG New Report 2019-09-16 93996
OXYCODONE PRO DOC LIMITEE To be discontinued 5MG New Report 2019-09-16 93993
ADENOCARD INJECTION -PRE-FILLED SYRINGE ASTELLAS PHARMA CANADA INC Discontinued 3MG Updated Report 2019-09-13 34494
APO-RABEPRAZOLE APOTEX INC Discontinued 10MG Updated Report 2019-09-12 40805
APO-TAMOX TAB 20MG APOTEX INC Discontinued 20MG Updated Report 2019-09-12 61050
TRAMADOL-ACET PRO DOC LIMITEE Discontinued 37.5MG 325MG Updated Report 2019-09-12 89923
ILARIS NOVARTIS PHARMACEUTICALS CANADA INC Discontinued 150MG Updated Report 2019-09-12 93588
VOLTAREN OPHTHA NOVARTIS PHARMACEUTICALS CANADA INC To be discontinued 0.1% New Report 2019-09-11 93561
VOLTAREN SR NOVARTIS PHARMACEUTICALS CANADA INC Discontinued 100MG Updated Report 2019-09-11 80298
HYDROMORPHONE HYDROCHLORIDE INJECTION USP PFIZER CANADA ULC Discontinued 10MG Updated Report 2019-09-09 77142